NOTICE: This website is no longer updated.
If you have questions about previously published Ontario COVID-19 Science Advisory Table resources, please email email@example.com.
Jump to Letter
Absolute risk difference
The absolute difference in the risk of an outcome, such SARS-CoV-2 infection or death between two groups. If an intervention reduces the absolute risk of death from 25% to 10%, the absolute risk difference is 15%. This is synonymous with risk difference and absolute risk reduction/increase. This is different from relative risk and relative risk reduction/increase.
A protein found on the surface of various cell types. It is considered to be a cellular entry receptor for the SARS-CoV-2 virus.
Acute respiratory distress syndrome (ARDS)
A serious form of lung injury that occurs in people who are critically ill, with a buildup of fluid in the lungs that prevents the effective exchange of oxygen. ARDS can be caused by the SARS-CoV-2 virus.
Adaptive immune system
A disease that is caused by a pathogen that can be transmitted through the air by very small particles called aerosols, which have the ability to remain suspended in the air over considerable time and distance.
Alternate level of care (ALC)
A type of hospital care that occurs when a patient is occupying a hospital bed but does not require typical hospital-level care such as acute care.
A large Y-shaped protein produced by the immune system to help in the identification and elimination of viruses and bacteria.
An individual who is infected with a pathogen but does not have symptoms.
Atrophy is a process by which a tissue degenerates and loses functional activity. The affected tissue may be replaced by other kinds of tissue.
The total number of new cases with an infection divided by the total population that was observed.
Typical clinical symptoms of COVID-19 are fever, cough, and respiratory distress. In the context of SARS-CoV-2 and COVID-19, atypical symptoms of COVID-19 can include confusion, weakness, vomiting and other symptoms not considered typical of an upper respiratory tract infection by clinicians.
A variant of concern of the SARS-CoV-2 virus that was first detected in India. This variant has two lineages: Kappa variant (B.1.617.1 variant) and Delta variant (B.1617.2 variant) This variant is also commonly known as the Indian variant.
The set of measurements at the beginning of a study.*
Basic reproduction number (R0)
An indication of how contagious an infectious disease is, defined as the
average number of cases generated by one case in a population in which all individuals are susceptible to infection in the absence of public health interventions and vaccines.
A measurable substance in an organism whose presence is indicative of a disease, infection, environmental exposure or other phenomenon.
C-reactive protein (CRP)
A protein produced by the liver that is a marker of inflammation in the body.
Case fatality rate
The proportion of people who die from a disease among those who are infected with it over a defined period of time. This is similar to case fatality ratio.
Case fatality ratio
The proportion of people who die from a disease among those who are infected with it. For example, in the context of SARS-CoV-2 and COVID-19, this would be the proportion of individuals who died of COVID-19 compared with the total number of individuals infected with SARS-CoV-2. This is synonymous with case fatality risk and is similar to case fatality rate.
A collaborative process of analysis, planning, support, evaluation, and advocacy for services to meet an individual’s comprehensive health needs. In the context of SARS-CoV-2 and COVID-19, it means ensuring that cases are reached in a timely and effective way to prevent the spread of SARS-CoV-2.
An examination and analysis of a particular instance (case), such as a person, population or event.
An observational study to find out the possible cause(s) of a disease or condition. This is done by comparing a group of patients who have the disease or condition (cases) with a group of people who do not have it (controls) but who are otherwise as similar as possible (in characteristics thought to be unrelated to the causes of the disease or condition).*
A cellular immune response that involves the activation of phagocytes, antigen-specific cytotoxic T lymphocytes, but does not involve the production of antibodies. This is synonymous with cellular immunity.
The count of the number of patients in the ICU on a given day.
The effect that something (for example, a public health intervention or a drug) is likely to have on a particular group of people. This is synonymous with clinical impact.*
The collection of information on an individual, usually through the performance of medical tests or physical exams.
A clinical study that examines and assesses the effects of a novel treatment, if it is safe, and if it works in people. Clinical trials are classified in 4 phases:
Phase I: The first time a new treatment or vaccine is tested in humans, it will usually be given to a small group of healthy volunteers, usually less than 50 participants. The principal objectives in Phase I are to make sure that the new medicine or vaccine presents no major safety issues, clarify that it can reach the targeted body area, remains there long enough to deliver its benefits, and gain preliminary evidence that it could offer therapeutic value, or prevent the disease or condition.
Phase II: If Phase I is successful, approval will be sought for a trial involving a larger group of people, usually several hundreds of participants. Phase II trials will typically include patients who have the disease the potential medicine is targeting and aim to establish the efficacy of the treatment or vaccine in treating or preventing the disease, and identify the optimal dose.
Phase III: If the results from Phase II are encouraging, a Phase III trial is conducted, which involves several hundreds to several thousands of participants coming from different countries. The objectives in Phase III are to evaluate the safety and effectiveness of the new treatment or vaccine in the typical patient likely to use it in clinical practice and identify side effects. If a new treatment or vaccine completes Phase III with positive results, regulatory approval might be sought.
Phase IV trials evaluate the treatment or vaccine after approval and frequently evaluates longer-term effects or compares effectiveness and safety of the new treatment with effectiveness and safety of established treatments. It typically involves several hundreds to several thousands of participants.
A longitudinal research study with two or more groups (cohorts) of people with similar characteristics.*
Separating a population into smaller groups (cohorts) in order to minimize their risk of infection, to contain an infection, and to easily trace close contacts in the case of infection. Members within each group must always remain the same, with no, or limited, contact with members from other cohorts.
A mathematical model that categorizes a population into groups, or “compartments”, where individuals may move between the model’s compartments, mapping the population’s epidemiological state. A SIR model is an example of a compartmental model.
Confidence interval (CI)
A way of expressing how certain we are statistically about the findings from a study. It gives a range of results that is likely to include the ‘true’ value for the population. A wide confidence interval indicates a lack of certainty about the true effect of the test or treatment – often because a small group of patients has been studied. A narrow confidence interval indicates a more precise estimate (for example, if a large number of patients have been studied). The confidence interval is usually stated as ‘95% CI’, which means that the range of values has a 95 in a 100 chance of including the ‘true’ value. For example, a study may state that ‘based on our sample findings, we are 95% certain that the ‘true’ population blood pressure is not higher than 150 and not lower than 110′. In such a case the 95% CI would be 110 to 150.*
A method used to keep track of individuals who have, or may have, come in contact with an infected individual.
A group of people in a study who do not have the intervention or test being studied. Instead, they may have the standard intervention or a placebo intervention. The results for the control group are compared with those a group receiving the intervention being tested. The aim is to check for any differences. Ideally, the people in the control group should be as similar as possible to those in the intervention group, to make it as easy as possible to detect any effects due to the intervention.*
A class of medications that mimics the effect of cortisol, a naturally occurring hormone, in the human body. Corticosteroids have potent anti-inflammatory effects and suppress the immune system.
An analysis that assesses the cost of achieving a benefit by different means. The benefits are expressed in non-monetary terms related to health, such as symptom-free days, heart attacks avoided, deaths avoided or life years gained (that is, the number of years by which life is extended as a result of the intervention). Options are often compared on the cost incurred to achieve one outcome (for example, cost per death avoided).*
A respiratory illness, formerly known as the 2019 novel coronavirus, caused by the virus SARS-CoV-2.
An observation of a set of people, or interventions, at one specific point in time. This contrasts with a longitudinal study, which follows a set of people over a period of time.*
The cumulative percentage of an at-risk population that develops a disease, becomes ill or dies from a disease during a specified period of time.
Cycle threshold (Ct)
The number of cycles needed to surpass the threshold of detection for SARS-CoV-2 in a PCR test. The PCR test identifies the virus by replicating its genetic material through enough cycles to make it detectable; the fewer cycles that are necessary to make viral material detectable, the more viral material there is.
Cytokine release syndrome
A multi-system inflammatory response in the body due to overactivation of the immune system. Cytokine release syndrome is a form of cytokine storm that is associated with chimeric antigen receptor T-cell (CAR-T) cancer therapy.
A multi-system inflammatory response in the body due to overactivation of the
A conceptual representation of data and various associations based on a set of parameters. In the context of SARS-CoV-2 and COVID-19, data modelling may be used to estimate how COVID-19, health systems changes, or other health-related variables may impact population outcomes. Mathematical modelling is a type of data modelling.
Decision analytic model
A mathematical model that is used to evaluate and compare competing public health interventions and medical interventions. The main goal is to assist with decision-making.
Deoxyribonucleic acid (DNA)
A type of genetic material that is found in all organisms and many viruses, and is usually double-stranded.
A type of corticosteroid medication.
An observational study where data is analyzed at a group, country or state level, rather than at an individual level.
Effective reproduction number (Rt, Re)
An indication of how contagious an infectious disease is in a specific population at a specific time, defined as the actual average number of cases generated by one case in the presence or absence of partial immunity, public health interventions and/or vaccines.
How beneficial a test or treatment is under usual or everyday conditions, compared with doing nothing or opting for another type of care.*
How beneficial a test, treatment, or public health intervention is under ideal conditions (for example, in a laboratory), compared with doing nothing or opting for another type of care.*
A disease that recurs in a particular area or population. The disease may also be considered native to that particular area or population.
The set of measurements at the end of a study.
The rapid spread of a disease to a large number of people in a population.
The study of the causes, distribution, control and prevention of disease. Epidemiologists collect and examine medical data and spot health trends to establish which diseases are on the increase and where, which treatments and other activities work and which do not. (This includes activities to prevent disease and to improve health and well-being.) In other words, they consider the possible risk factors for a whole population or area, not just for individual patients.*
Work that is considered critical to protecting life, health, or public functioning. In Ontario, essential work in the context of SARS-CoV-2 and COVID-19 includes, but is not limited to, grocery store workers, gas station workers, truck drivers, long-term care home staff, trades workers, health care workers, first responders, warehouse and distribution workers, and manufacturing workers. This is synonymous with essential services.
The number of deaths from all causes during a crisis, above and beyond what would have been expected under normal conditions.
Extra-corporeal membrane oxygenation (ECMO)
A machine used to oxygenate the blood of a person with severe heart or lung injury. With ECMO, blood is transferred from the body to a heart-lung machine that removes carbon dioxide and adds oxygen and the blood is then returned to the body.
The hazard or chance of an event occurring in the treatment arm of a study as a ratio of the chance of an event occurring in the control arm over time.*
A substance or toxin that has the potential to be damaging to the liver.
High-flow nasal cannula
A device used to provide oxygen to a patient with moderate oxygen requirements or moderate respiratory difficulty. The flow of oxygen is up to 60 L/min. A high flow nasal cannula can increase the oxygen concentration to 24-100% (for reference, the percentage of inspired oxygen in the environment is 21%). A high flow nasal cannula provides a fixed oxygen concentration.
The organ system that is involved in protecting people from infection, infestation, and other potential harm from infections by pathogens.**
The number of new cases of a disease among a certain group of people during a specific period of time. To be distinguished from prevalence.*
The period between the initial infection and the onset of signs and/or symptoms.**
Infection prevention and control (IPAC)
A multidisciplinary field that applies evidence-based practices and procedures to health care settings to reduce the transmission of infection.
A family of viruses that cause the respiratory illness commonly known as the “flu”. The severity of infection with influenza can be mild, with symptoms such as fever and cough, or severe, manifesting as injury to the lungs that require mechanical ventilation.
Interleukins are proteins that can act as signalling molecules for the immune system and regulate the immune response and inflammation. Interleukin-6 is released in response to infections and acts as a signal to increase the inflammatory response to infections with microbes such as SARS-CoV-2.
Interrupted time series
A method of statistical analysis that involves tracking a long period of time before and after a specific identified point, in order to determine the impact and effect of that point.
A procedure used to administer a drug into the muscle tissue, enabling the drug to be more easily absorbed into the bloodstream. Flu shots are given this way.
A patient with COVID-19 experiences lasting symptoms for an extended period of time after infection. Long COVID cases can last for months; the maximum duration is not yet known.
A study of the same group of people at different times. This contrasts with a cross-sectional study, which observes a group of people at a point in time.*
The use of a machine to help a person with breathing when they are unable to breathe effectively on their own.
A protein that is bound to the wall of a cell.
Memory B cell
Memory T cell
Messenger ribonucleic acid (mRNA)
A type of RNA that carries the genetic code for a specific protein, and conveys this code from the DNA to the ribosome, which produces the protein. mRNA is the intermediate step between the protein-encoding DNA and the production of proteins.
A method often used in systematic reviews to combine results from several studies of the same test, treatment or other intervention to estimate the overall effect of the treatment.*
Middle East Respiratory Syndrome (MERS)
A respiratory illness caused by the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The virus was first identified in 2012. MERS may present as a mild respiratory illness with fever and cough or as a severe respiratory illness causing injury to the lungs.
A prolonged suspension of an action or regulation, which is to be repealed by a subsequent consideration at a later date. For example, a COVID-19 eviction moratorium may suspend the eviction of individuals or households who have lost income due to the pandemic and cannot pay rent.
The number of cases of an illness, injury, or condition within a given time (usually a year). It can also refer to the percentage of people with a particular illness, injury or condition within a defined population.*
The proportion of a population that dies within a particular period of time. The rate is often given as a certain number per 1,000 people.*
A statistical way of smoothing data by taking an average over a period of time, for example 7 days. This is synonymous with rolling average and running average.
A vaccine that works by introducing an mRNA sequence into its host. The mRNA “teaches” the host cells to build a protein specific to the virus that the vaccine is intended to protect against. The protein is then recognized as non-self and the immune system begins generating antibodies, protecting the host from future infection.
Multisystem inflammatory syndrome
A condition where different organ systems can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.
An analysis of one dependent variable measuring an outcome and multiple independent variables meant to predict the outcome.
A mutation of the SARS-CoV-2 virus.
Variants with the N501Y mutation are referred to as N501Y+ variants. This mutation has allowed the variants to be more transmissible by permitting the SARS-CoV-2 virus to more readily bind to ACE2 receptors. This includes the Alpha variant (B.1.1.7 variant), the Beta variant (B.1.351 variant), and Gamma variant (P.1 variant).
Variants without the N501Y mutation are referred to as N501Y- variants. This includes the Delta variant (B.1.617.2 variant).
A device used to provide oxygen to a patient with low oxygen requirements and minimal respiratory difficulty. It is a plastic tube with two ports that fit into the nose. Nasal prongs can increase the oxygen concentration (FiO2) to 25-40% (for reference, the percentage of inspired oxygen in the environment is 21%). However, the actual delivered concentration of oxygen through nasal prongs can be variable between people, particularly in the context of respiratory difficulty.
A method of collecting a clinical test sample which involves a swab of the secretions located in the back of the nose and throat.
Natural immunity is the antibody protection your body creates against an infection once you’ve been infected with it. Natural immunity varies according to the person and the infection type.
Negative likelihood ratio
The ratio of the probability that a negative test result is incorrect (a false negative) to the probability that a negative test result is correct (a true negative). Expressed differently, it is the probability of a negative test in an individual with a specific disease or condition divided by the probability of a negative test in an individual without the specific disease or condition. It is calculated using the sensitivity and specificity of the test (1- sensitivity / specificity).
An antibody that is capable of keeping a virus from infecting a cell by neutralizing or completely inhibiting its biological effect.**
A low neutrophil cell count. Neutrophils are a type of white blood cell and part of the immune response to infection.
The average number of patients who need to receive the treatment or other intervention for one of them to get the positive outcome in the time specified. The closer the NNT is to 1, the more effective the treatment. For example, if the NNT for drug A compared with drug B for pain relief after a tooth extraction is 4, on average, for every four people who get drug A instead of drug B, one person will have pain relief after tooth extraction who would not have done if all four had got drug B. The other three people out of the four will have or not have pain relief, just as if they had taken drug B. The NNT is 100 divided by the absolute risk reduction (ARR) expressed as a percentage. For example, if the ARR is 5%, the NNT is 100/5=20.*
A health care field that involves the well-being and safety of workers in the workplace. In the context of SARS-CoV-2 and COVID-19, occupational health includes the provision of necessary personal protective equipment and the implementation of appropriate health and safety measures in the workplace to prevent the transmission of SARS-CoV-2.
Compares the odds (probability) of something happening in one group with the odds of it happening in another. An odds ratio of 1, shows that the odds of the event happening (for example, a person developing a disease or a treatment working) is the same for both groups. An odds ratio of greater than 1 means that the event is more likely in the first group than the second. An odds ratio of less than 1 means that the event is less likely in the first group than in the second group.*
The use of a drug in a manner other than the one defined on the drug label, and not as approved by Health Canada.
The use of a drug in the manner defined on the drug label, as approved by Health Canada.
A measure of the strength of the evidence against the null hypothesis; the smaller the p-value, the stronger the evidence against the null hypothesis. A p-value of less than 0.05 is typically considered to indicate statistical significance. A p-value of less than 0.005 can be considered strong evidence against the null hypothesis. This is synonymous with significance levels.
An epidemic of an infectious disease that has spread across a large region, for instance multiple continents.
An agent causing disease or illness, such as a virus or bacterium capable of producing a disease.**
A review of a study, service or recommendation by those with similar interests and expertise to the people who produced it to make sure a study and the report describing it are accurate and valid.*
Period of viral replication
The time period during which a virus is actively replicating within a host.
The quantification of the amount of follow-up that accumulated in a group of people or in a study, which takes into account both the number of individuals in the study and the amount of time spent each individual spent in the study. For example, 1,000 individual years of data will be used in an analysis that tracked 1,000 individuals for 1 year.
Personal protective equipment (PPE)
In the context of SARS-CoV-2 and COVID-19, this is equipment that provides protection to the body and face in order to avoid exposure to SARS-CoV-2 infection. For example, medical or N95 masks, goggles, gowns, and face shields.
A study that develops branching diagrams (phylogenetic trees) that represent the relationship between different mutations of SARS-CoV-2. A phylogenetic tree is characterised by a series of branching points, expanding from the most recent common ancestor. The branches represent the passage of genetic information between generations, and the length of the branches represents genetic changes.
An inert treatment, such as a sugar pill or saline injection, given to patients in the control group of a clinical trial. It is indistinguishable from the actual treatment, which is given to patients in the experimental group. The aim is to determine the effect of the experimental treatment over and above any perceived benefit someone has because of participating in the clinical study and receiving the inert treatment (placebo effect).
A highly contagious virus that targets the central nervous system, causing paralysis. Infected individuals are often asymptomatic.
Polymerase chain reaction (PCR)
A study that is representative for the entire population addressed in the study question.
Positive likelihood ratio
The ratio of the probability that a positive test result is correct (a true positive) to the probability that a positive test result is incorrect (a false positive). Expressed differently, it is the probability of a positive test in an individual with a specific disease or condition divided by the probability of a positive test in an individual without the specific disease or condition. It is calculated using the sensitivity and the specificity of the test (sensitivity / 1- specificity).
The probability that an individual has a specific disease or condition after a diagnostic test, taking into account the pre-test probability, the test result, and the performance (sensitivity and specificity) of the test.
The state after infection, but before the development of symptoms.
How common a disease or condition is within a population, either at a point in time or over a given period of time, including new and existing cases. This is different from incidence.*
A research study in which the health or other characteristic of patients is monitored (or ‘followed up’) for a period of time, with events recorded as they happen. This contrasts with retrospective studies.*
A medication that alters brain functions (for example, vision, consciousness, awareness). Examples include antidepressants, benzodiazepines, and antipsychotic medications. This is synonymous with psychotropic drug.
Public health intervention
In the context of SARS-CoV-2 and COVID-19, a measure taken to contain the pandemic, such restricting mass gatherings, social distancing, or closing schools. This is synonymous with public health measures.
Randomized controlled trial (RCT)
A study in which a number of similar people are randomly assigned to two (or more) groups to test a specific drug, treatment, or other intervention. One group (the experimental group) has the intervention being tested, the other (the comparison or control group) has an alternative intervention, a dummy intervention (placebo) or no intervention at all. The groups are followed up to examine the effectiveness of the experimental intervention. Outcomes are measured at specific times and any difference in response between the groups is assessed statistically. This method is also used to reduce bias. A randomized controlled trial is a type of clinical trial.*
Rapid antibody test
Rapid antigen test
Diagnostic test that identifies COVID-19 in a nose or throat by detecting proteins attached to the surface of the virus (the “antigen”), as opposed to genetic material. When the sample is added to the testing device, it flows along an absorbent pad that contains nanoparticles designed to bind to the surface proteins if they are present, and produce a colored line similar to a pregnancy test. This type of test can be performed by non-expert and provides quick results.
Rapid antigen-based test
Rapid PCR test
A form of evidence synthesis in which components of the systematic review process are simplified or taken out in order to provide information to reach conclusions in a timely manner.
A form of a relative risk. It is a way to express the probability of an event occurring in the study group during a specific time compared with the probability of the same event occurring in the control group during the same time. If both groups face the same level of risk, the rate ratio is 1. If the first group had a rate ratio of 2, subjects in that group would be twice as likely to have the event happen. A rate ratio of less than 1 means the outcome is less likely in the first group.*
An element or substance that is added to a compound in order to create chemical a reaction that will allow the user to detect or measure other substances.
A statistical method used to investigate the relationship between two or more variables and estimate one variable dependent on the others. In the context of COVID-19, it helps to predict COVID-19 outbreaks.
An estimate of the ratio of the probability of an outcome in one group compared to the probability of an outcome in another group. A relative risk of 1 indicates that there is no difference between the two compared groups. A risk ratio is an estimate of the relative risk.
Saliva and respiratory secretions which are expelled when a person exhales (for example, coughs, sneezes, speaks). Droplets are defined by their size (they are usually greater than 5 to 10 micrometers in diameter) and characteristic pattern of quickly falling to the ground from gravitational forces. Pathogens that are transmitted via respiratory droplets are suspended within the respiratory droplets and, thus, do not tend to travel for large distances or time. However, smaller droplets can dry out and stay airborne.
A research study that focuses on the past and present. The study examines past exposure to suspected risk factors for the disease or condition. Unlike prospective studies, it does not cover events that occur after the study group is selected.*
Ribonucleic acid (RNA)
A type of genetic material that is found in all organisms and many viruses, and is usually single-stranded.
A ratio of the risk of an outcome in one group compared to the risk of an outcome in another group. This is an estimate of the relative risk.
Severe Acute Respiratory Syndrome Coronavirus 2; the novel strain of coronavirus that causes coronavirus disease 2019 (COVID-19).
A second significant and sustained surge in SARS-CoV-2 infections after a sustained decrease in SARS-CoV-2 infections in a particular region. This is synonymous with wave two.
How well a test detects what it is testing for. It is the proportion of people with the disease or condition that are correctly identified by the study test. For example, a test with a sensitivity of 96% will, on average, correctly identify 96 people in every 100 who truly have the condition, but incorrectly identify as not having the condition 4 people in every 100 who truly have it. This is different from positive predictive value.*
Serious adverse event
A test that detects the presence of antibodies in blood serum, which are usually produced in response to an infection. In a serological test, antibodies are detected in the serum irrespective of the presence of symptoms.
The proportion of people in a population who test positive for a specific disease based on serological tests.
Severe Acute Respiratory Syndrome (SARS)
An viral respiratory disease caused by SARS-CoV-1, a coronavirus genetically related to SARS-CoV-2.
A process of developing a mathematical representation of an actual or proposed product in a computer model.
A study that is conducted at a single site (for example, a hospital or clinic) and in accordance with a single protocol or set of parameters.
A type of compartmental model that has three compartments: S, denoting the number of susceptible individuals; I, denoting the number of infected individuals; and R, denoting the number of recovered individuals. In the context of SARS-CoV-2 and COVID-19, this model can be used to analyze and predict the spread of the SAR-CoV-2 virus.
Maintaining a physical distance between people or groups of people to prevent the spread of an infectious disease. This is synonymous with physical distancing.
A substance or protein that dissolve in blood or other body or cellular fluids.
How well a test correctly identifies people who do not have what it is testing for. It is the proportion of people without the disease or condition that are correctly identified by the study test. For example, a test with a specificity of 96% will, on average, correctly identify 96 people in every 100 who truly do not have the condition, but incorrectly identify as having the condition 4 people in every 100 who truly do not have it.*
A piece or portion of a sample selected for examination.**
A protein with the shape of spike that studs the surface of SARS-CoV-2 and other coronaviruses, giving them the appearance of a crown.
Social inequities that are theoretically remediable and are unequal or unreasonable towards a particular population. This is synonymous with systemic inequities.
An option of infusing fluid into subcutaneous tissue that requires only minimal equipment. This therapy is used to treat or prevent dehydration.
According to Canada’s National Occupancy Standard (NOS), suitable housing refers to whether the building has a sufficient number of bedrooms for the size and composition of the household inhabiting the dwelling.
A care in which patients with low blood oxygen levels are provided with oxygen by a holding tank of oxygen or a compressor. Oxygen is then delivered through a nose tube or a mask.
The systematic collection and analysis of data in a population.
In the context of SARS-CoV-2 and COVID-19, this refers to a case of COVID-19 disease that presents with typical and/or atypical symptoms. Common symptoms include, but are not limited to, fever, loss of taste and/or smell, dry cough, chest tightness, fatigue, runny nose. COVID-19 may also exhibit gastrointestinal symptoms.
The systematic collection and analysis of health indicators, assisted by automated data acquisition and generation of statistical alerts, in real-time to detect disease outbreaks earlier than would be possible with traditional public health methods.
A review that summarizes the evidence on a clearly formulated review question according to a predefined protocol, using systematic and explicit methods to identify, select and appraise relevant studies, and to extract, analyze, collate and report their findings. It may or may not use statistical techniques, such as meta-analysis.*
A type of white blood cell developed in the lymphoid organ of the immune system. These cells are involved in cell-mediated immunity and play a major role when a foreign agent attacks the body. This is synonymous with T lymphocyte.
Test to Stay
When individuals who have been exposed to someone with COVID-19 are offered daily rapid antigen testing as an alternative to self-isolation so long as they test negative and remain asymptomatic for a defined risk period after exposure.
Threshold analysis quantifies how much a parameter could change before conclusions change or the direction of an effect changes.
A low platelet count.
A curve used to describe the length of time until the occurrence of defined clinical events in a group of people. The occurrence of events are typically indicated by steps in the curve.
A statistical analysis involving only one dependent and one independent variable.
A suspension containing live, attenuated, modified, or killed pathogens, genetic material (such as RNA), or proteins that encodes for part of a pathogen. When the vaccine is administered into the body stimulates the body’s immune system to produce antigen-specific antibodies.**
The percentage reduction of disease in a vaccinated group of people compared to an unvaccinated group, using the most favorable conditions. It is expressed as a percentage and calculated as (1-relative risk) x 100.
Variant of concern (VOC)
In the context of SARS-CoV-2 and COVID-19, it is a genetic variation of the SARS-CoV-2 virus that may potentially have an impact on SARS-CoV-2 transmissibility, COVID-19 severity, or effectiveness of COVID-19 vaccines or treatments.
A device used to provide oxygen to a patient with moderate oxygen requirements or moderate respiratory difficulty. A venturi mask can increase the oxygen concentration to 24-60% (for reference, the percentage of inspired oxygen in the environment is 21%). A venturi mask provides a fixed oxygen concentration.
The number of viral particles in a clinical specimen (for example, saliva, blood plasma).
The act of spreading a virus through respiratory or other body fluids.
An evolved form of a virus that underwent a mutation or a number of mutations that changed part of the original virus’ genetic code. This evolution may impact the virus’ transmissibility, morbidity, or mortality.
Voluntary (Asymptomatic) Screen Testing
The practice of testing asymptomatic individuals at regular intervals in settings where individuals congregate outside of their household and there is a moderate risk of SARS-CoV-2 transmission, such as schools and workplaces.
The examination of sewage water to detect and monitor pollutants (for example, mercury) and biomarkers, to obtain data on the activities and health of the community living within the catchment area. Wastewater testing has been previously used to detect drug use (for example, opioid use), as well as the presence of viruses (for example, poliovirus) within a community, and can be used to detect components of SARS-CoV-2.
Wastewater treatment plant
A facility that uses physical, chemical, and biological processes to remove pollutants from sewage water.
An average of data points calculated after weighting each data point by its statistical precision or another measure of importance of the data point.
*The definitions for these terms were adapted from the National Institute for Health Care and Excellence (NICE) glossary.
**The definitions for these terms were adapted from the Biology Online dictionary.